Research Use Only. Retatrutide / Cagrilintide Blend is sold as a chemical reagent for in-vitro laboratory research. It is not a drug, supplement, or compounded preparation, and it is not for human or veterinary use. It must be handled by qualified professionals. Wholesale Peptide Supply is not a pharmacy or compounding facility under 503A or 503B.
Wholesale Retatrutide / Cagrilintide Blend — Bulk Research Supply
Buy Retatrutide / Cagrilintide Blend wholesale and in bulk from a US-based research peptide supplier. Every lot is sourced in the USA and third-party tested via HPLC/MS. Bulk Retatrutide / Cagrilintide Blend is quoted by dose and volume from a 100-vial mix-and-match minimum; volume pricing is earned per compound at 100 kits.
A dual-agent research formulation pairing retatrutide, a triple-pathway receptor agonist, with cagrilintide, a long-acting amylin analog. Studied where triple-agonist and amylin pathway signaling are examined together.
Wholesale Catalog
Available Doses
Published per-vial wholesale pricing for Retatrutide / Cagrilintide Blend. Sold in kits of 10 vials with a 100-vial order minimum you can mix and match across compounds; volume pricing applies at 1,000+ vials. Contact us for larger or custom-volume quotes — typically answered within 10 minutes during business hours.
Retatrutide / Cagrilintide Blend 10mg (5/5)50% off
WPSRC10 · CAS Multi-component · Custom Blends
$29.90$14.95/vial · 50% off at any volumeWhile supplies last
Discontinued — limited to stock on hand. Once it's gone, it's gone. Sold in kits of 10 vials · 100-vial order minimum (mix & match across compounds).
Overview
A dual-agent research formulation pairing retatrutide, a triple-pathway receptor agonist, with cagrilintide, a long-acting amylin analog. Studied where triple-agonist and amylin pathway signaling are examined together.
History
Pairs the most recently characterized multi-pathway agonist with a long-acting amylin analog, supplied as a single reconstitution for combined-pathway study designs.
Where this sits against the Cagrilintide / Semaglutide blend
Two cagrilintide blends are stocked and they overlap by half, so it is worth being explicit about which is which. Both pair 5 mg of cagrilintide, a long-acting amylin analogue, with 5 mg of an incretin-pathway agonist. The amylin arm is identical; the partner is not.
This blend uses retatrutide, a triple-pathway agonist active at GLP-1, GIP and glucagon receptors. The Cagrilintide / Semaglutide blend uses semaglutide, which is active at GLP-1 alone.
So this is the broader-coverage preparation of the two, and the pair is most informative used together: with amylin held constant, the difference between them is purely how many incretin pathways are engaged alongside it. Substituting one for the other silently narrows or widens half the formulation.
Key Areas of Research
- Triple-pathway receptor agonism
- Amylin receptor pathway signaling
- Combined vs. single-pathway comparative models
References
- Coskun T. et al. (2022). LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist. Cell Metab, 34(9):1234–1247.
- Enebo L.B. et al. (2021). Concomitant cagrilintide and semaglutide. Lancet, 397(10286):1736–1748.
Retatrutide / Cagrilintide Blend — Frequently Asked Questions
- What is Retatrutide / Cagrilintide Blend?
- A dual-agent research formulation pairing retatrutide, a triple-pathway receptor agonist, with cagrilintide, a long-acting amylin analog. Studied where triple-agonist and amylin pathway signaling are examined together.
- What doses of Retatrutide / Cagrilintide Blend are available wholesale?
- Wholesale Peptide Supply stocks Retatrutide / Cagrilintide Blend in 10mg (5/5). Wholesale pricing is provided by quote based on order volume across 100–1,000 vials.
- Is Retatrutide / Cagrilintide Blend third-party tested?
- Yes. Every lot of Retatrutide / Cagrilintide Blend is tested by an independent third-party laboratory using HPLC/MS, and a per-lot Certificate of Analysis documenting identity and purity is included with every order at no charge, issued in the name of Wholesale Peptide Supply.
- Is Retatrutide / Cagrilintide Blend for human use?
- No. Retatrutide / Cagrilintide Blend is sold strictly as a chemical reagent for in-vitro laboratory research and is not for human or veterinary use. Wholesale Peptide Supply is not a pharmacy or compounding facility.
- How do I get wholesale pricing for Retatrutide / Cagrilintide Blend?
- Request a quote through our contact form or open a wholesale account. An account manager replies with volume pricing and lead times, typically within 10 minutes during business hours.
- Can I order Retatrutide / Cagrilintide Blend in bulk?
- Yes. Retatrutide / Cagrilintide Blend is available for bulk and wholesale orders, quoted by dose and volume, with the lower price earned per compound at 100 kits (1,000 vials). Submit the doses and quantities you need for a bulk quote.
Related Compounds
Custom Blends
GLOW Blend
The GLOW Blend combines GHK-Cu, BPC-157, and TB-500 in a single research formulation, studied across structural, epithelial, vascular, and systemic models.
View details →Custom Blends
KLOW Blend
The KLOW Blend extends the GLOW formulation with the addition of KPV, adding cytokine-modulating and immune signaling properties to the structural and vascular base blend.
View details →Custom Blends
Cagrilintide / Semaglutide Blend
A dual-agent research formulation pairing cagrilintide, a long-acting amylin analog, with semaglutide, a long-acting GLP-1 receptor agonist. Studied in laboratory models where amylin and incretin pathway signaling are examined together.
View details →Custom Blends
Semax / Selank Blend
A research formulation pairing Semax, an ACTH(4-10) analog, with Selank, a tuftsin analog. Both are Russian-developed regulatory peptides and are frequently studied side by side in neuropeptide research.
View details →GLP-1 & Metabolic
Semaglutide
Semaglutide is a synthetic peptide analog that functions as a long-acting pathway agonist, structurally modified for extended half-life and improved target binding affinity. It is studied in preclinical and laboratory models for its ability to activate target pathways and modulate downstream molecular signaling associated with endocrine regulation.
View details →GLP-1 & Metabolic
Tirzepatide
Tirzepatide is a synthetic peptide that functions as a dual pathway agonist, designed as a once-weekly investigational compound studied in preclinical laboratory models for receptor-mediated signaling and modulation of downstream cascades.
View details →GLP-1 & Metabolic
Retatrutide
Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.
View details →Growth Hormone
Ipamorelin
Ipamorelin is a synthetic pentapeptide and selective secretagogue-type agonist with minimal off-target pathway interference, used to study endocrine signaling and somatotroph axis modulation.
View details →